Respirology

Top Medical News
Elvira Manzano, Yesterday
The benefits of mRNA* COVID-19 vaccines far outweigh the very small risk of vaccine-related myocarditis, says the US Centers for Disease Control and Prevention (CDC).
Yesterday
Vaping an electronic waterpipe, which is also known as e-hookah, adversely affects the vasculature—an effect that is partly mediated by inflammation—a study has found.
Elvira Manzano, Yesterday
A rapid and affordable test for diagnosing COVID-19 outside the walls of the healthcare units could improve case-finding, contact tracing, and infection control, says an expert during a pre-ECCMID 2021 session.
Pearl Toh, 2 days ago
While RT-PCR is the current gold standard to confirm a SARS-CoV-2 infection, antigen rapid test (ART) for COVID-19 allows for quick detection of SARS-CoV-2 and thus fast triaging of infected patients requiring isolation at the population level, according to studies presented at ECCMID 2021.
Roshini Claire Anthony, 3 days ago

Use of prednisone prior to SARS-CoV-2 diagnosis may be linked to a higher risk of severe COVID-19 outcomes such as hospitalization, intensive care unit (ICU) admission, and death, according to a retrospective community-based study.

Roshini Claire Anthony, 4 days ago

Same-day pre-event screening for SARS-CoV-2 using antigen-detecting rapid diagnostic tests (Ag-RDT) may enable the resumption of large-scale indoor events which were halted or had their attendance capacity reduced during the COVID-19 pandemic, according to a study from Spain presented at ECCMID 2021.

Roshini Claire Anthony, 5 days ago

Long-term care facility (LTCF) residents aged 65 years appeared to be protected from COVID-19 4–7 weeks after receiving their first dose of the ChAdOx1 nCoV-19 or BNT162b2 vaccine, according to a study presented at ECCMID 2021.

Special Reports
Pearl Toh, 29 Jul 2021
While RT-PCR is the current gold standard to confirm a SARS-CoV-2 infection, antigen rapid test (ART) for COVID-19 allows for quick detection of SARS-CoV-2 and thus fast triaging of infected patients requiring isolation at the population level, according to studies presented at ECCMID 2021.
16 Jun 2021
Ceftaroline fosamil 600 mg powder for infusion
Prof. David Paterson, 30 Mar 2021
Intensive care unit (ICU) patients are at risk of developing serious infections with multidrug-resistant organisms (MDROs), which require appropriate and adequate antibiotic coverage. Early empirical coverage is pivotal in saving patients’ lives. At a recent webinar co-organized by the Society of Infectious Disease (Singapore) and Pfizer, renowned Professor David Paterson, Professor of Medicine and Director, The University of Queensland Centre for Clinical Research, and Consultant Infectious Diseases Physician, Royal Brisbane and Women’s Hospital, Brisbane, Australia, discussed the role of newer antimicrobial agents, including ceftazidime-avibactam (Zavicefta) in the management of MDROs in the ICU. Dr Wong Sin Yew, Infectious Disease Physician at Gleneagles Medical Centre and Mount Elizabeth Novena Specialist Centre, Singapore, chaired the event.
Dr. Asok Kurup, Dr. Kenneth Chan, 07 Dec 2020
The rising incidence of infections caused by multidrug-resistant (MDR) gram-negative bacteria has become a serious health threat and a major challenge for intensivists. Against a backdrop of high patient mortality and risk factors for infection in intensive care units (ICU), early adequate therapy is of paramount importance. At a recent Pfizer-sponsored symposium, Dr Asok Kurup, Infectious Disease Physician, Singapore presented the implications of MDR gram-negative infections in critically ill patients in Asia, while Dr Kenneth Chan, Respiratory Physician and Intensivist, Singapore highlighted the role of ceftazidime-avibactam (Zavicefta) and shared published real-world data on ceftazidime-avibactam. 
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
01 Nov 2020
As the COVID-19 pandemic continues to spread around the globe, comparison is often drawn to influenza, another contagious respiratory-borne disease. Recently, Dr Azureen Azmel, a consultant infectious disease physician at Hospital Tengku Ampuan Rahimah (HTAR), and Dr Leong Chee Loon, a consultant infectious disease physician with Hospital Kuala Lumpur (HKL), came together to discuss about the importance of annual influenza vaccination during the current COVID-19 pandemic.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Conference Reports
Elvira Manzano, 29 Jul 2021
A rapid and affordable test for diagnosing COVID-19 outside the walls of the healthcare units could improve case-finding, contact tracing, and infection control, says an expert during a pre-ECCMID 2021 session.
Pearl Toh, 29 Jul 2021
While RT-PCR is the current gold standard to confirm a SARS-CoV-2 infection, antigen rapid test (ART) for COVID-19 allows for quick detection of SARS-CoV-2 and thus fast triaging of infected patients requiring isolation at the population level, according to studies presented at ECCMID 2021.
Roshini Claire Anthony, 27 Jul 2021

Same-day pre-event screening for SARS-CoV-2 using antigen-detecting rapid diagnostic tests (Ag-RDT) may enable the resumption of large-scale indoor events which were halted or had their attendance capacity reduced during the COVID-19 pandemic, according to a study from Spain presented at ECCMID 2021.

Roshini Claire Anthony, 26 Jul 2021

Long-term care facility (LTCF) residents aged 65 years appeared to be protected from COVID-19 4–7 weeks after receiving their first dose of the ChAdOx1 nCoV-19 or BNT162b2 vaccine, according to a study presented at ECCMID 2021.

Audrey Abella, 23 Jul 2021
Findings from real-world studies presented at ECCMID 2021 showed improved survival outcomes with remdesivir in hospitalized COVID-19 patients.

Audrey Abella, 21 Jul 2021
The monoclonal antibody regdanvimab showed promise in the treatment of patients with mild-to-moderate* COVID-19, a pivotal phase II/III trial has shown.
Elaine Soliven, 25 Jun 2021
Treatment with a fixed-dose combination of budesonide and albuterol (BDA) in a single pressurized metered-dose inhaler (pMDI), also known as PT027, significantly prevents exercise-induced bronchoconstriction (EIB) in adolescents and adults with asthma, according to the TYREE* study presented at ATS 2021.